Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Home Stocks Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw

Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw

Stocks,

It looks to build a pipeline of 28 biosimilars across global markets in three phases.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...

All Copyright @ Trendmergers Team

Crafted With By Templatesyard | Distributed By Gooyaabi Templates

Breaking

Post Top Ad

Post Top Ad

Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw

Post Top Ad

Recent

Contact

Footer menu

Post Of the day

Popular Posts

Contact Form